EAACI Congress 2024
BackFT 17 - Flash talks on Angioedema
Sunday 02 Jun, 13:15 PM -
14:45 PM Valencia, Spain
Palma
Flash Talks
13:15
The Determinants of Acute Attack Development in Hereditary Angioedema Patients Undergoing Dental Interventions
13:22
Real-world Effectiveness of Lanadelumab in Patients with HAE Type I/II: Data across the Four Countries from the INTEGRATED Study
13:29
A Physician-based Brazilian Registry for Hereditary Angioedema: insights from the first 508 Patients
13:36
Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment
13:43
Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients' Quality of Life and Treatment Compliance Level
13:50
Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
13:57
Attack-free Rates and Attack Characteristics in Patients with Hereditary Angioedema Receiving Non-androgen Long-term Prophylaxis
14:04
Use of Patient-Reported Outcome Measurements Among Angioedema-Treating Physicians
14:11
Evaluation of Anxiety, Depression, and Death Anxieties in Patients Diagnosed with Hereditary Angioedema
14:18
Pharmacodynamic Effects of Deucrictibant on Carrageenan-induced Edema in Humanized Bradykinin B2 Receptor Transgenic Sprague Dawley Rat
14:25
Development of Kallikrein-Kinin System Biomarker Assays to Investigate Bradykinin-mediated Diseases
14:32
Exploring the Relationship Between Airway Attacks and Patient-Reported Outcomes in Hereditary Angioedema
